Monday, February 17, 2020

Finn Wolfhard - FWOLF (Short) - HSX Pick of the Day for February 17, 2020

Finn Wolfhard is best known for his work on "Stranger Things," but his movie dance card has been jam-packed, appearing in three films in 2019, with two in 2020 and one in 2021. Volume is the most valuable asset for a StarBond on the Hollywood Stock Exchange, so it's always worth watching a stock like this. Sure enough, FWOLF offers big opportunity, both in the short term as well as the medium and long terms.

On Wednesday, February 19th, FWOLF will adjust to reflect the box office from The Turning, knocking the horror smash It out of TAG range. It earned more than $327 million, so it falling out of TAG range for FWOLF would drop his stock $50 per share. The Turning has currently grossed $15,141,565. If you build in some padding and place it at $16,000,000, that's $3.20 per share increase, meaning FWOLF will land $46.80 per share lower than it's current TAG of $114,144,985. This means FWOLF will adjust to roughly $67.32 on Wednesday, meaning that if you short the stock, you will earn $17.70 per share guaranteed, a profit of 20.8%.

Beyond the immediate windfall, FWOLF offers some area for profit that, while not guaranteed, is highly likely and worthy of your investment. FWOLF's next film to fall out of TAG range is Dog Days, which grossed $6,807,030, and will be replaced by the new Ghostbusters movie in July. It's inconceivable to imagine it won't gross north of $6,807,030, and at the current price of $147.47, it will likely gross far, far more.

Recommendation: Immediately short as many shares of FWOLF as you can afford, and then quickly cover the short on Wednesday once the stock adjusts. After adjust, buy as many shares as you can and watch the stock quickly climb in value.

Friday, February 7, 2020

Frozen II - FROZ2.BW - Blockbuster Warrant

Frozen II has been another runaway box office success for Disney, grossing $472,819,959 and counting. HSX predicted big things for the film, setting the Blockbuster Warrant at a high $370,000,000, but clearly the film has toppled that number with ease. At the current price, you would expect the warrant to trade at roughly $102, since that is the guaranteed payout. Yet FROZ2.BW is currently trading at $20.66, more than $80 below value. That means if you buy the max number of shares, you'll walk away with more than $1.626 million in just a few weeks.


Recommendation: No matter the size of your portfolio, buy as many shares as you can and hold them until they cash out for a quick, big boost to your portfolio.

Knives Out - $100M Blockbuster Warrant - HSX Pick of the Day for February 7, 2020

Rian Johnson's Knives Out has been a runaway hit, earning an Oscar nomination, major box office, and an upcoming sequel. As of February 7, 2020, the film has earned $156,359,119 in domestic box office.


Last month, HSX issued a derivative allowing HSX investors to invest in the film's long-term box office success. The threshold for the derivative was set at $100M, meaning that for every $1M grossed beyond that, the derivative would increase in share $1M. Given the current box office haul for Knives Out, the derivative should be trading at a minimum of $56.35, as this is the minimum value of the derivative once it prices out even if the film doesn't make another dollar (unlikely since the film is still grossing a couple of hundred thousand dollars per day). Yet the derivative is currently trading at $17.11, a guaranteed $39.24 below value.


This means that if you buy the maximum 20,000 shares of the stock, you are guaranteed at least $784,800 when the derivative cashes out in two weeks with absolutely no risk.


Recommendation: This is a no-brainer for any size portfolio, as your stock will more than triple in value in just two weeks.

Monday, December 12, 2016

TVStocks - ABC's Designated Survivor

ABC has been very pleased with the ratings for the Kiefer Sutherland vehicle Designated Survivor, ordering a full 22 episode season not long after it debuted.  While ratings have dipped a bit since, they still remain strong, and there's no reason to think the show will not be renewed.  With 22 episodes ordered, there's little reason to justify the stock's current price of $19.61, as it should adjust to $22 on May 31, 2017, a 12.2% increase in 5.5 months, approximately 25% annually.

Designated Survivor could suddenly tank in the ratings, but there's almost nothing to suggest that DESURV won't adjust to $22 at the end of May.

Recommendation: If you have a small portfolio and need to invest in big, quick gains, DESURV isn't the stock for you.  But if you have plenty of investible funds and need somewhere to invest, DESURV offers a nice pickup for you.

Jemaine Clement - HSX Pick of the Day for December 12, 2016

Jemaine Clement, star of Flight of the Conchords, provides the voice of Tamatoa in Walt Disney's Moana, a film that has topped the box office in each of its first three weeks of release, earning $144.7 million through Sunday, December 11th.  Assuming a very conservative $10 million in gross in its fourth week, the film would adjust to $155 million.  Moana will replace What We Do In The Shadows  in Jemaine Clement's TAG, a film that grossed just $3,276,317.  As a result, JCLEM will adjust up by a minimum of $30.34, putting his price at $42.11, up from his current price of $26.59.

Even if Moana were to somehow make no additional money over its current $144.7 million, JCLEM would still adjust to $40.05, a big profit over his current value.

Recommendation: Buy JCLEM long.  After MOANA adjusts on December 20th, you would be wise to dump your stock in JCLEM.  While his next film to drop from TAG range, Misery Loves Comedy, grossed just $5,260, it looks to be awhile until Clement appears in his next film, which will likely cause the stock to drop until the release date of his next effort approaches.

Thursday, December 17, 2015

Julie Walters - HSX Pick of the Day for December 17, 2015

It's been more than four years since the final film in the Harry Potter franchise was released, but for the savvy investor, Harry and his friends still offer great opportunities for easy and guaranteed money on the HSX market.

Julie Walters (JWALT) appeared as Molly Weasley in the Harry Potter Series, and since the release of the last film has popped up in just four additional credits, most recently this year's Brooklyn.  Brooklyn will de-list for somewhere between $15 and $18 million on December 22nd, and will enter JWALT's TAG range and push Gnomeo and Juliet out of TAG range.  Gnomes and Juliet grossed $99,908,609, so even if we assume that Brooklyn tops out at $18 million, that's a difference of $81,908,609, or $16.38 in TAG value, dropping her TAG from $132.67 to roughly $116.29.  JWALT is currently trading at $130.84, offering a gain of $14.55 (11%) per share in just one week to anyone savvy enough to short stock in JWALT.

As if that wasn't attractive enough, more profits are almost certainly on the horizon.  The next film to fall out of TAG range is the final Harry Potter film, which grossed more than $381 million.  While the Hollywood Stock Exchange does not list her next film (she has been busy shooting Indian Summers), assuming that Ms. Walters appears on screen again, her next film will almost certainly drop the value of JWALT dramatically as Harry Potter is pushed out of TAG range.  The worst case scenario for an investor is that her next film grosses north of $250 million, which would keep her stock at exactly it's post-December 22nd price.  Even if her next film was enormously successful and grossed $150 million, that would cause a drop in value of $30 per share, a gain to short sellers of roughly 26%.  It might take awhile to collect, but with such a significant potential gain, investing in JWALT is a no brainer.

One more note: JWALT's next film to fall out of TAG range after Harry Potter is Brave, which brought home more than $237 million for Disney.  Short selling JWALT will almost certainly offer big money for a long time to come.

RECOMMENDATION: Short as many shares of JWALT as you can afford, and hold onto them for a long time.

Monday, June 9, 2014

6/10/2014 Pick - Marion Cotillard

Marion Cotillard (MCOTI) offers a great Hollywood Stock Exchange short opportunity.  Marion Cotillard will adjust today, and her TAG will gain Blood Ties and lose Midnight in Paris.  Blood Ties has earned less than a million dollars, while Midnight in Paris earned $56.82 million, meaning her TAG will fall over $11.00 per share from a current value of $64.47 to around $54 million.  It's too late to get in on this drop, as the stock is frozen, but there's still time to make HSX money by shorting Marion Cotillard.

In 8 weeks, Marion Cotillard will adjust again to account for The Immigrant, dropping Contagion in the process.  The Immigrant currently has grossed at $1,421,859.  Even if it were to gross $5 million, which is unlikely, Contagion grossed $75,638,743, meaning MCOTI would drop approximately $14 a share, to around $40, offering a gain of over $24.

If that's not enough for you and you're willing to hold onto MCOTI even longer, the next movie to drop from TAG range will be The Dark Knight Rises, which grossed almost $450 million.  This offers zero risk, since even if Cotillard's next film were to become the highest grossing film in film history, the stock would maintain its post The Immigrant price due to TAG rules.  Even if the film is successful, this could offer huge opportunities.

As soon as MCOTI is unfrozen, make sure to short sell as many shares of Marion Cotillard as you can afford.  It can offer a good short-term or great long-term profit.